Treace Medical Concepts, Inc. Impairment of Leasehold
Treace Medical Concepts, Inc. (TMCI) reported Impairment of Leasehold of $100.00 thousand for the 3-month period ending 2022-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLeasehold · last filed 2025-02-27
- Treace Medical Concepts, Inc. impairment of leasehold for the quarter ending 2022-12-31 was $100.00K.
- Treace Medical Concepts, Inc. impairment of leasehold for fiscal 2022 was $100.00K.
| Period end | Impairment of Leasehold 3 month | Impairment of Leasehold 12 month |
|---|---|---|
| 2022-12-31 | $100.00K 10-K · filed 2025-02-27 | $100.00K 10-K · filed 2024-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |